Literature DB >> 8741370

Morphological effects of tumor necrosis factor-alpha on the blood vessels in rat experimental brain tumors.

T Isaka1, T Yoshimine, M Maruno, T Hayakawa.   

Abstract

The morphological changes in the vascular endothelium caused by the administration of tumor necrosis factor-alpha (TNF-alpha) were studied in an experimental model of rat brain tumors. Wistar rats bearing implanted C6 glioma received human natural-type TNF-alpha (1.7 x 10(5) U/m2) through the carotid artery and were sacrificed 3 or 24 hours later. The endothelial cells of the tumor blood vessels, demonstrated by the immunoreaction to factor VIII-related antigen, were enlarged after TNF-alpha administration. Morphometry demonstrated that the nuclei of these endothelial cells were also increased in size. The endothelial cells in the brain remote to the tumor were not affected. An in vitro binding study demonstrated that TNF-alpha binding sites were distributed in the vascular endothelial cells within the tumor but not in the brain remote to the tumor. The selective effect of TNF-alpha on the tumor blood vessels in experimental brain tumors may be related to the selective distribution of the TNF-alpha binding site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741370     DOI: 10.2176/nmc.36.423

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

1.  Distribution of endogenous tumour necrosis factor alpha in gliomas.

Authors:  M Maruno; J S Kovach; P J Kelly; T Yanagihara
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.

Authors:  Chandrakala Menon; Antoinette Ghartey; Robert Canter; Michael Feldman; Douglas L Fraker
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Ultrastructural changes of the vascular endothelium after intra-arterial administration of tumor necrosis factor-alpha (TNFalpha) in rat gliomas.

Authors:  T Isaka; M Maruno; A K Muhammad; A Kato; H Nakagawa; T Yoshimine
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.